Recent News

• 05.26.2026 - NeoGenomics to Present New Research at ASCO Annual Meeting 2026
• 05.15.2026 - NeoGenomics to Participate in Upcoming Investor Conferences
• 04.28.2026 - NeoGenomics Reports First Quarter 2026 Results
• 04.23.2026 - NeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura Integration
• 04.13.2026 - NeoGenomics to Present Multiple Abstracts Showcasing New Research at AACR Annual Meeting 2026
• 04.07.2026 - NeoGenomics to Report First Quarter 2026 Financial Results on April 28, 2026

Recent Filings

• 05.22.2026 - 8-K Current report
• 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.13.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.13.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.13.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.07.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.05.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.05.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.05.2026 - 4 Statement of changes in beneficial ownership of securities
• 04.30.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors